Atossa Therapeutics (ATOS) SEC Filings & 10K Form $1.41 -0.01 (-0.70%) (As of 11/4/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recent Atossa Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView10/22/20242:24 PMAtossa Therapeutics (Subject)BlackRock, Inc. (Filed by)Form SC 13G08/12/20248:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/12/20248:05 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/23/202411:15 PMAtossa Therapeutics (Filer)Form EFFECT05/23/20248:00 AMAtossa Therapeutics (Filer)Form DEF 14A05/14/20243:46 PMAtossa Therapeutics (Filer)Form DEL AM05/13/20248:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/13/20248:05 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/10/20248:00 AMAtossa Therapeutics (Filer)Form PRE 14A05/10/20248:04 AMAtossa Therapeutics (Filer)Form ARS03/18/20247:35 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/14/20247:30 PMAtossa Therapeutics (Issuer)Cigler Tessa (Reporting)Form 3Initial statement of beneficial ownership of securities 03/14/20247:35 PMAtossa Therapeutics (Issuer)Cigler Tessa (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/12/20247:30 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/15/20233:05 PMAtossa Therapeutics (Issuer)Finn Jonathan (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/13/20238:10 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/13/20238:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/09/20238:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CorMedix 10Q Form Tourmaline Bio 10Q Form Oculis 10Q Form ABIVAX Société Anonyme 10Q Form Astria Therapeutics 10Q Form Y-mAbs Therapeutics 10Q Form Stoke Therapeutics 10Q Form Entrada Therapeutics 10Q Form Tango Therapeutics 10Q Form Acelyrin 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ATOS) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATOS Stock Alerts